Allopurinol

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Allopurinol and local guidelines before prescribing.

Xanthine oxidase inhibitor

Mechanism

Xanthine oxidase inhibitor reducing uric acid production.

Uses

Gout prevention, tumour lysis prophylaxis, recurrent urate stones.

Dosing

2 more dose entries from the chapters

Side effects

Rash, GI upset; rarely severe hypersensitivity (HLA-B*58:01), hepatitis, marrow suppression.

Interactions

Azathioprine and mercaptopurine toxicity rises (reduce doses); ampicillin rash more likely.

Contraindications and cautions

HLA-B*5801 carriers at higher risk of severe rash; avoid starting during an acute flare

Monitoring

Urate every few weeks to target below 360 micromol/L, creatinine, LFT, rash

Pregnancy and breastfeeding

Specialist advice

Renal and hepatic impairment

Start low and titrate in renal impairment

Overdose and reversal

Supportive

Special advice

Do not start in an acute attack; start low and titrate with serum urate; cover with colchicine or NSAID when starting; stop at first rash.

More from the textbook: uses, cautions and other points
Where it is discussed in the book